ConductScience.org, home

Paper29445192

SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma.

Saini M and 2 others. Cell Death Dis, 2018. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma. Papers, record 29445192. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29445192

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma.
PubMed
Journal
Cell Death Dis
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
0.76
iCite
Revised in PubMed
2025-05-30
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Saini MMasum
2Verma AAakanksha
3Mathew SJSam J

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gene Expression Regulation, NeoplasticMajor topic
Intracellular Signaling Peptides and ProteinsMajor topic
Membrane ProteinsMajor topic
Proto-Oncogene Proteins c-metMajor topic
Cell Differentiation
Cell Line, Tumor
Cell Movement
Cell Proliferation
Child
Humans
Lymphatic Metastasis
Muscle Development
Organ Specificity
Protein Binding
Protein Stability
RNA, Small Interfering
Rhabdomyosarcoma, Alveolar
Rhabdomyosarcoma, Embryonal
Signal Transduction

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Wellcome TrustUnited KingdomPubMed
IA/I/13/1/500872DBT-Wellcome Trust India AllianceIndiaPubMed

Source PubMed

Download CSV of grants

References53

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11717137Muscle-specific gene expression in rhabdomyosarcomas and stages of human fetal skeletal muscle development.Cancer Res1991https://conductscience.org/library/papers/1717137PubMed
219536876Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005.Cancer2009https://conductscience.org/library/papers/19536876PubMed
39472005Cell heterogeneity upon myogenic differentiation: down-regulation of MyoD and Myf-5 generates 'reserve cells'.J Cell Sci1998https://conductscience.org/library/papers/9472005PubMed
49473336HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells.Dev Biol1998https://conductscience.org/library/papers/9473336PubMed
523665679Proof-of-concept rare cancers in drug development: the case for rhabdomyosarcoma.Oncogene2014https://conductscience.org/library/papers/23665679PubMed
621575221Inhibition of phosphorylated c-Met in rhabdomyosarcoma cell lines by a small molecule inhibitor SU11274.J Transl Med2011https://conductscience.org/library/papers/21575221PubMed
711478764ERK pathway positively regulates the expression of Sprouty genes.Biochem Biophys Res Commun2001https://conductscience.org/library/papers/11478764PubMed
812783965Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas.J Clin Pathol2003https://conductscience.org/library/papers/12783965PubMed
98622890Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas.Oncogene1996https://conductscience.org/library/papers/8622890PubMed
106590967Molecular cloning of a new transforming gene from a chemically transformed human cell line.Nature1984https://conductscience.org/library/papers/6590967PubMed
1111846609Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.Methods2001https://conductscience.org/library/papers/11846609PubMed
129398440Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells.Dev Biol1997https://conductscience.org/library/papers/9398440PubMed
1322672386Expression of proto-oncogene KIT is up-regulated in subset of human meningiomas.BMC Cancer2012https://conductscience.org/library/papers/22672386PubMed
1410805738p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps.Mol Cell Biol2000https://conductscience.org/library/papers/10805738PubMed
158633043Pax3 modulates expression of the c-Met receptor during limb muscle development.Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8633043PubMed
1615122328Overexpression of sprouty 2 inhibits HGF/SF-mediated cell growth, invasion, migration, and cytokinesis.Oncogene2004https://conductscience.org/library/papers/15122328PubMed
1714685170Met, metastasis, motility and more.Nat Rev Mol Cell Biol2003https://conductscience.org/library/papers/14685170PubMed
1811698404Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of Raf.J Biol Chem2002https://conductscience.org/library/papers/11698404PubMed
199693375Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly.Mol Biol Cell1998https://conductscience.org/library/papers/9693375PubMed
2016861966An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children's Oncology Group experience.Am J Surg Pathol2006https://conductscience.org/library/papers/16861966PubMed

See all 53 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
42140968Emergence of Sprouty role from the signaling interplay of DUSP1 and DUSP4 interactions in NSCLC pathogenesis.NPJ Syst Biol Appl2026https://conductscience.org/library/papers/42140968PubMed
41929490Intact lymph node homing and CD8+ T-cell priming abilities of Sprouty2-deficient dendritic cells.Front Immunol2026https://conductscience.org/library/papers/41929490PubMed
41021275Functional Variant Discovery Identifies a Novel Genetic Link between SPRY2, Wood Smoke, and Asthma.Am J Respir Cell Mol Biol2026https://conductscience.org/library/papers/41021275PubMed
39970235Inhibiting mechanotransduction prevents scarring and yields regeneration in a large animal model.Sci Transl Med2025https://conductscience.org/library/papers/39970235PubMed
38463968Rapid evolution of genes with anti-cancer functions during the origins of large bodies and cancer resistance in elephants.bioRxiv2024https://conductscience.org/library/papers/38463968PubMed
38177411The Wnt-pathway corepressor TLE3 interacts with the histone methyltransferase KMT1A to inhibit differentiation in Rhabdomyosarcoma.Oncogene2024https://conductscience.org/library/papers/38177411PubMed
37097161Targeting exosomes enveloped EBV-miR-BART1-5p-antagomiRs for NPC therapy through both anti-vasculogenic mimicry and anti-angiogenesis.Cancer Med2023https://conductscience.org/library/papers/37097161PubMed
37045830PKD phosphorylation and COP9/Signalosome modulate intracellular Spry2 protein stability.Oncogenesis2023https://conductscience.org/library/papers/37045830PubMed
36998041Epithelioid and spindle rhabdomyosarcoma with TFCP2 rearrangement in abdominal wall: a distinctive entity with poor prognosis.Diagn Pathol2023https://conductscience.org/library/papers/36998041PubMed
36033507Non-coding RNA in rhabdomyosarcoma progression and metastasis.Front Oncol2022https://conductscience.org/library/papers/36033507PubMed
35008205The Effect of Direct and Indirect EZH2 Inhibition in Rhabdomyosarcoma Cell Lines.Cancers (Basel)2021https://conductscience.org/library/papers/35008205PubMed
33919702Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas.Cancers (Basel)2021https://conductscience.org/library/papers/33919702PubMed
33568634Alternative splicing of ceramide synthase 2 alters levels of specific ceramides and modulates cancer cell proliferation and migration in Luminal B breast cancer subtype.Cell Death Dis2021https://conductscience.org/library/papers/33568634PubMed
32517051The MNK1/2-eIF4E Axis as a Potential Therapeutic Target in Melanoma.Int J Mol Sci2020https://conductscience.org/library/papers/32517051PubMed
30874331The Sprouty/Spred family as tumor suppressors: Coming of age.Cancer Sci2019https://conductscience.org/library/papers/30874331PubMed
30591655Effects of SAHA and EGCG on Growth Potentiation of Triple-Negative Breast Cancer Cells.Cancers (Basel)2018https://conductscience.org/library/papers/30591655PubMed
29971532Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines.J Cancer Res Clin Oncol2018https://conductscience.org/library/papers/29971532PubMed

Download CSV of cited by

Genes23

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
CASP3836PubTator's text mininghttps://conductscience.org/library/genes/836NCBI Gene
CCND1595PubTator's text mininghttps://conductscience.org/library/genes/595NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
FOXO12308PubTator's text mininghttps://conductscience.org/library/genes/2308NCBI Gene
GAPDH2597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
HGF3082PubTator's text mininghttps://conductscience.org/library/genes/3082NCBI Gene
HLA-C3107PubTator's text mininghttps://conductscience.org/library/genes/3107NCBI Gene
HPRT13251PubTator's text mininghttps://conductscience.org/library/genes/3251NCBI Gene
MAP2K75609PubTator's text mininghttps://conductscience.org/library/genes/5609NCBI Gene
MAPK15594PubTator's text mininghttps://conductscience.org/library/genes/5594NCBI Gene
MET4233PubTator's text mininghttps://conductscience.org/library/genes/4233NCBI Gene
MIR27A407018PubTator's text mininghttps://conductscience.org/library/genes/407018NCBI Gene
MYOD14654PubTator's text mininghttps://conductscience.org/library/genes/4654NCBI Gene
MYOG4656PubTator's text mininghttps://conductscience.org/library/genes/4656NCBI Gene
PAX35077PubTator's text mininghttps://conductscience.org/library/genes/5077NCBI Gene
PAX75081PubTator's text mininghttps://conductscience.org/library/genes/5081NCBI Gene
POTEF728378PubTator's text mininghttps://conductscience.org/library/genes/728378NCBI Gene
RET5979PubTator's text mininghttps://conductscience.org/library/genes/5979NCBI Gene
SLTM79811PubTator's text mininghttps://conductscience.org/library/genes/79811NCBI Gene

See all 23 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29445192

GET https://conductscience.org/api/papers/v1/29445192/references?page=2